Suggestions
Adel Malek
Chief of Neurovascular Surgery at Tufts Medical Center
Dr. Adel Malek is a prominent neurosurgeon and medical innovator who was appointed as the Chief Medical Officer of CereVasc, Inc. in March 2023.1 He brings a wealth of experience and expertise to this role, making him a valuable addition to the company's leadership team.
Professional Background
Dr. Malek holds several distinguished positions in the field of neurosurgery:
- Chief of Neurovascular Surgery at Tufts Medical Center
- Director of the Cerebrovascular and Endovascular Division in the Department of Neurosurgery at Tufts Medical Center
- Professor of Neurosurgery at Tufts University School of Medicine12
Education and Training
Dr. Malek's educational background is impressive:
- Medical degree from Harvard Medical School
- Doctorate in medical engineering and Physics from the Massachusetts Institute of Technology
- Neurosurgical training at Brigham and Women's/Children's Hospital Boston
- Neurointerventional radiology fellowship at the University of California, San Francisco2
Expertise and Research
Dr. Malek is board-certified in neurosurgery and specializes in:
- Multi-modal and minimally invasive treatment of brain aneurysms
- Treatment of arteriovenous malformations (AVMs) and dural arteriovenous fistulas (DAVFs)
- Research on cellular and hemodynamic mechanisms in brain aneurysms and AVMs
- Development of endovascular technologies2
Role at CereVasc
As the Chief Medical Officer and co-founder of CereVasc, Dr. Malek plays a crucial role in the company's mission to develop novel, minimally invasive treatments for neurological diseases.12 He is a co-inventor of the eShunt endovascular device, which is designed to treat communicating hydrocephalus.1
Dr. Malek expressed his enthusiasm for his role at CereVasc, stating that he is "Grateful to be part of this exciting journey to provide a less invasive endovascular treatment approach to hydrocephalus for our patients!"3
Highlights
Thank you to the organizers of the 30th Congress of the European Society of Gene and Cell Therapy for the opportunity to share the exciting work and innovation in non-invasive next-generation endovascular Gene/ASO/Cell delivery being developed at CereVasc Inc. using the eShunt catheter technology. Grateful to the team of Matthew Gounis, Heather Gray-Edwards and Vania Anagnostakou for help validating CereVasc's novel cerebello-pontine cistern approach! #genetherapy #drugdelivery #esgct2023 #brainhealth #brainresearch #oligonucleotides #celltherapy #brainsurgery #endovascular #neurointervention
Grateful for Dr. Pedro Lylyk, his superb team at Clinica Sagrada Familia in Buenos Aires, Argentina and CereVasc for taking the first step in the minimally invasive percutaneous/endovascular treatment of hydrocephalus.
